Available as Retatrutide 25MG + Cagrilintide 5MG or Retatrutide 12.5MG + Cagrilintide 2.5MG per vial. Each set contains 10 research vials.
Contact online support for real-time help with product selection, bulk orders, shipping, or payment.
One clear reference point for this compound, its format, and the supplied product information.
Choose Retatrutide 25MG + Cagrilintide 5MG per vial or Retatrutide 12.5MG + Cagrilintide 2.5MG per vial. Pack size: 10 vials.
Reta+Cagrilintide combines two distinct metabolic research references in proportional configurations. The two available specifications let laboratories plan comparative concentration work while keeping product identification and inventory straightforward.
Retatrutide is investigated across GLP-1, GIP, and glucagon receptor pathways. Cagrilintide is a long-acting amylin analogue studied in relation to amylin-receptor signaling. Together, the components provide a model for examining complementary pathway behavior and experimental interaction.
RT 25 + Cagrilintide 5 or RT 12.5 + Cagrilintide 2.5
Keep sealed, protected from direct light, and under conditions appropriate to the individual components and the laboratory's validated procedures. Record lot identity and handling conditions throughout the study.
Research use only. Not for human consumption, diagnostic use, or therapeutic application.
Key answers before shipping, dispatch, and after-sales details.
Worldwide delivery in 8–15 days with air dispatch on business days.
Tracking provided on every order.
Invalid test results → Full refund.
Dedicated support team with clear pre- and post-payment updates.
Brazil orders require CPF/CNPJ for local tax handling.
Contact our online support for real-time communication about products, orders, shipping, payment, or bulk supply.